Subscribe
MoleMapCD technology from DigitalDerm allows patients and doctors to monitor potentially deadly changes in the skin with accuracy and objectivity, the company says.
Melanoma rate still on the rise
Topical tacrolimus clears peristomal PG
150 immunology trials in melanoma surveyed
Videodermatoscopy beyond pigmented lesions
Joseph Gorelick, MSN, FNP-C
Brad P. Glick, DO, MPH, FAAD
Hilary Baldwin; Neal Bhatia, MD
Tina Bhutani, MD
June 17-19, 2026
Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD
Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc
Andrew Alexis, MD, MPH; Leon Kircik, MD
Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD
Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD